Related Experiment Video
Updated: Mar 12, 2026

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
EYA1's Conformation Specificity in Dephosphorylating Phosphothreonine in Myc and Its Activity on Myc Stabilization in
Jun Li1, Yoel Rodriguez2,3, Chunming Cheng1
1Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Abstract:
EYA1 is known to be overexpressed in human breast cancer, in which the Myc protein is also accumulated in association with decreased phospho-T58 (pT58) levels. We have recently reported that EYA1 functions as a unique protein phosphatase to dephosphorylate Myc at pT58 to regulate Myc levels. However, it remains unclear whether EYA1-mediated Myc dephosphorylation on T58 is a critical function in regulating Myc protein stability in breast cancer. Furthermore, EYA1's substrate specificity has remained elusive. In this study, we have investigated these questions, and here, we report that depletion of EYA1 using short hairpin RNA (shRNA) in breast cancer cells destabilizes the Myc protein and increases pT58 levels, leading to an increase in the doubling time and impairment of cell cycle progression. In correlation with EYA1-mediated stabilization of cMyc and reduced levels of pT58, EYA1 greatly reduced cMyc-FBW7 binding and cMyc ubiquitination, thus providing novel insight into how EYA1 acts to regulate the FBW7-mediated Myc degradation machinery. We found that the conserved C-terminal haloacid dehalogenase domain of EYA1, which has been reported to have only tyrosine phosphatase activity, has dual phosphatase activities, and both the N- and C-terminal domains interact with substrates to increase the catalytic activity of EYA1. Enzymatic assay and nuclear magnetic resonance (NMR) analysis demonstrated that EYA1 has a striking conformation preference for phospho-T58 of Myc. Together, our results not only provide novel structural evidence about the conformation specificity of EYA1 in dephosphorylating phosphothreonine in Myc but also reveal an important mechanism contributing to Myc deregulation in human breast cancer.
Insights
EYA1 dephosphorylates Myc at T58, stabilizing it and promoting breast cancer cell growth. Depleting EYA1 destabilizes Myc, hindering cell cycle progression and revealing a key mechanism in cancer.
Area of Science:
- Molecular Biology
- Biochemistry
- Cancer Research
Background:
- EYA1 is overexpressed in breast cancer, correlating with Myc accumulation and decreased phospho-T58 (pT58) levels.
- EYA1 acts as a protein phosphatase, dephosphorylating Myc at pT58 to regulate Myc levels.
- The precise role of EYA1-mediated Myc dephosphorylation in breast cancer and EYA1's substrate specificity remain unclear.
Purpose of the Study:
- To investigate the critical function of EYA1-mediated Myc dephosphorylation in regulating Myc protein stability in breast cancer.
- To elucidate the substrate specificity of EYA1.
- To understand the structural and mechanistic basis of EYA1's phosphatase activity on Myc.
Main Methods:
- Depletion of EYA1 using short hairpin RNA (shRNA) in breast cancer cells.
- Analysis of Myc protein stability, pT58 levels, cell doubling time, and cell cycle progression.
- Investigation of c-Myc binding to FBW7 and c-Myc ubiquitination.
- Enzymatic assays and nuclear magnetic resonance (NMR) analysis to determine EYA1's phosphatase activity and substrate specificity.
Main Results:
- EYA1 depletion destabilized Myc, increased pT58 levels, slowed cell doubling, and impaired cell cycle progression.
- EYA1 stabilized c-Myc by reducing c-Myc-FBW7 binding and ubiquitination.
- EYA1 possesses dual phosphatase activities (not just tyrosine phosphatase) and interacts with substrates via both N- and C-terminal domains.
- EYA1 exhibits conformational specificity for phospho-T58 of Myc.
Conclusions:
- EYA1 dephosphorylation of Myc at T58 is critical for Myc protein stability and breast cancer cell proliferation.
- EYA1 regulates the FBW7-mediated Myc degradation pathway, offering a novel mechanism for Myc deregulation in cancer.
- EYA1 has dual phosphatase activities and specific conformational preference for phospho-T58 of Myc, providing structural insights into its function.
Related Concept Videos
Mitogens and the Cell Cycle
Abnormal Proliferation
Induced Pluripotent Stem Cells
Somatic...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Master Transcription Regulators
Anaphase Promoting Complex

